Mainz Biomed N.V (MYNZ) EPS (Basic): 2022-2023
Historic EPS (Basic) for Mainz Biomed N.V (MYNZ) over the last 2 years, with Dec 2023 value amounting to -$12.38.
- Mainz Biomed N.V's EPS (Basic) rose 45.26% to -$12.38 in Q4 2023 from the same period last year, while for Dec 2023 it was -$67.81, marking a year-over-year increase of 15.80%. This contributed to the annual value of -$22.36 for FY2024, which is 65.47% up from last year.
- Mainz Biomed N.V's EPS (Basic) amounted to -$12.38 in Q4 2023, which was up 17.72% from -$15.05 recorded in Q3 2023.
- In the past 5 years, Mainz Biomed N.V's EPS (Basic) registered a high of -$12.38 during Q4 2023, and its lowest value of -$23.11 during Q2 2022.
- Its 2-year average for EPS (Basic) is -$18.54, with a median of -$18.73 in 2022.
- Data for Mainz Biomed N.V's EPS (Basic) shows a peak YoY surged of 45.26% (in 2023) over the last 5 years.
- Quarterly analysis of 2 years shows Mainz Biomed N.V's EPS (Basic) stood at -$22.62 in 2022, then soared by 45.26% to -$12.38 in 2023.
- Its EPS (Basic) stands at -$12.38 for Q4 2023, versus -$15.05 for Q3 2023 and -$22.26 for Q2 2023.